The latest report by IMARC Group, titled "Australia Oxygen Concentrator Market Report by Type (Portable, Stationary), Technology (Continuous Flow, Pulse Flow), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress, Others), End User (Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers and Physician Offices), and Region 2025-2033," offers a comprehensive analysis of the Australia oxygen concentrator market growth. The report includes competitor and regional analysis, along with a detailed breakdown of the market segmentation. The Australia oxygen concentrator market size reached USD 98.00 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 189.21 Million by 2033, exhibiting a CAGR of 6.80% during 2025–2033.
Base Year: 2024
Forecast Years: 2025–2033
Historical Years: 2019–2024
Market Size in 2024: USD 98.00 Million
Market Forecast in 2033: USD 189.21 Million
Market Growth Rate (2025–2033): 6.80%
Australia Oxygen Concentrator Market Overview
The Australian oxygen concentrator market is witnessing significant growth, driven by several key factors. The rising prevalence of respiratory conditions such as COPD and asthma—highlighted by the AIHW’s 2024 report showing an 8.5% increase in asthma burden since 2003—is fueling demand for oxygen therapy. At the same time, technological advancements in oxygen delivery systems, growing awareness of the benefits of home-based oxygen therapy, and improved healthcare infrastructure are contributing to market expansion.
The aging population is another major driver, with projections indicating that 25% of Australians will be aged 65 or older by 2064–65. This demographic shift is increasing the need for reliable and accessible oxygen therapy solutions. Additionally, government healthcare initiatives and changes in aged care policy are supporting wider access to these devices.
Patients’ growing preference for home-based care—reducing the need for frequent hospital visits—further strengthens the market. The availability of both portable and stationary oxygen concentrators enhances accessibility and convenience, positioning the Australian market for sustained growth and improved patient outcomes.
Request For Sample Report:
https://www.imarcgroup.com/australia-oxygen-concentrator-market/requestsample
Australia Oxygen Concentrator Market Trends
• Respiratory disease prevalence increase: Rising chronic respiratory conditions particularly COPD and asthma with 2024 Burden of Disease Study showing asthma accounting for 11.9% of total disease burden in children 5-14 years.
• Home care therapy preference: Growing patient choice for home-based oxygen therapy providing convenience, comfort, and reduced hospital visits particularly appealing to elderly and chronic disease patients.
• Portable technology advancement: Enhanced portable oxygen concentrator development offering mobility, independence, and active lifestyle maintenance for patients requiring continuous or intermittent oxygen therapy.
• Geriatric population expansion: Demographic shift with 25% of population projected to be 65+ by 2064-65 creating sustained demand for age-related respiratory condition management solutions.
• Government healthcare reforms: Implementation of aged care improvements and Indigenous Australian health support addressing life expectancy disparities and healthcare access inequalities.
• Affordability improvement: Increased availability of cost-effective oxygen con